Table 1.
Initial assessment | First versus second assessments | |||||||
Baseline | Dobutamine stress | Normal subset | Abnormal subset | |||||
Variables | Patients (n=26) | Controls (n=20) | Patients (n=26) | Controls (n=20) | First assessment (n=14) | Second assessment (n=14) | First assessment (n=10) | Second assessment (n=10) |
RR (s) | 0.80 (0.15) | 0.79 (0.16) | 0.78 (0.13)** | 0.70 (0.13) | 0.82 (0.16) | 0.82 (0.14) | 0.77 (0.15) | 0.71 (0.14) |
ET (s) | 0.30 (0.03) | 0.30 (0.03) | 0.29 (0.05)** | 0.26 (0.04) | 0.30 (0.02) | 0.29 (0.04) | 0.31 (0.03) | 0.33 (0.03) |
FS (%) | 0.38 (0.05) | 0.41 (0.05) | 0.47 (0.07)*** | 0.54 (0.04) | 0.38 (0.05) | 0.35 (0.05) | 0.35 (0.02) | 0.32 (0.04)* |
EF (%) | 0.76 (0.06) | 0.80 (0.06) | 0.84 (0.08)*** | 0.90 (0.03) | 0.76 (0.07) | 0.71 (0.07) | 0.76 (0.05) | 0.68 (0.06)*** |
Vcfc (circ/s) | 1.11 (0.16) | 1.23 (0.21) | 1.42 (0.24)*** | 1.73 (0.26) | 1.13 (0.16) | 1.09 (0.15) | 1.08 (0.17) | 0.82 (0.11)*** |
WS (g/cm2) | 64.34 (14.23) | 72.67 (11.65) | 59.89 (22.80)** | 46.18 (15.57) | 65.03 (16.38) | 72.89 (14.68) | 63.11 (11.90) | 60.10 (9.62) |
Ferritin (μmol/l) | – | – | – | – | 4253 (792) | 4935 (831) | 5647 (769) | 6741 (1347)* |
Values are mean (SD).
*p<0.05; **p<0.01; ***p<0.001.
EF, ejection fraction; ET, ejection time; FS, fractional shortening; RR, RR interval; Vcfc, rate corrected velocity of circumferential fibre shortening; WS; meridional wall stress.